Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132726) titled 'Diagnostic and Prognostic Value of Novel Coagulation Biomarkers in Sepsis-Associated Coagulopathy' on Sept. 17.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Beijing Hospital
Condition:
Sepsis-induced coagulopathy
Intervention:
Gold Standard:SIC score = 4
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-25
Target Sample Size: Target condition:480;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343988
Published by HT Digital Content Services with permiss...